Validation of an Allergy Clinical Decision Rule for "Sulfa" antibiotic allergy label – S-FAST

Journal of Allergy and Clinical Immunology(2023)

引用 0|浏览9
暂无评分
摘要
Recent studies suggest Trimethoprim-sulfamethoxazole (Co-T) rechallenge is safe in those with low-risk allergy histories. We aimed to validate an established point- of-care clinical decision rule to guide risk stratification for patients whose use of Co-T is limited by a sulfa antibiotic label.
更多
查看译文
关键词
allergy clinical decision rule,antibiotic allergy label,sulfa,s-fast
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要